IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 71
Titolo Data di pubblicazione Autore(i) File
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 1-gen-2004 Salvatore, Giuliana; Giannini, R; Faviana, P; Caleo, A; Migliaccio, I; Fagin, Ja; Nikiforov, Ye; Troncone, G; Palombini, L; Basolo, F; Santoro, M.
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 1-gen-2004 Decker, T; Oelsner, M; Kreitman, Rj; Salvatore, Giuliana; Wang, Qc; Pastan, I; Peschel, C; Licht, T.
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 1-gen-2004 Lima, J; Trovisco, V; Soares, P; Maximo, V; Magalhaes, J; Salvatore, Giuliana; Santoro, M; Bogdanova, T; Tronko, M; Abrosimov, A; Jeremiah, S; Thomas, G; Williams, D; SOBRINHO SIMOES, M.
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 1-gen-2005 Melillo, Rm; Castellone, Md; Guarino, V; DE FALCO, V; Cirafici, Am; Salvatore, Giuliana; Caiazzo, F; Basolo, F; Giannini, R; Kruhoffer, M; Orntoft, T; Fusco, A; Santoro, M.
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 1-gen-2005 Guida, T; Salvatore, G; Faviana, P; Giannini, R; Garcia-Rostan, G; Provitera, L; Basolo, F; Fusco, A; Carlomagno, F; Santoro, M.
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 1-gen-2005 Salvatore, Giuliana; Chiappetta, G; Nikiforov, Y; DECAUSSIN PETRUCCI, M; Fusco, A; Carney, Ja; Santoro, M.
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 1-gen-2005 Guarino, V; Faviana, P; Salvatore, G; Castellone, Md; Cirafici, Am; De Falco, V; Celetti, A; Giannini, R; Basolo, F; Melillo, Rm; Santoro, M.
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 1-gen-2005 Rostn, G; Costa, Am; Pereiracastro, I; Salvatore, Giuliana; Moreira, S; Hernandez, R; Herrero, A; Fusco, A; Teijeiro, J; Santoro, M.
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 1-gen-2006 Rhoden, Kj; Unger, K; Salvatore, Giuliana; Yilmaz, Y; Vovk, V; Chiappetta, G; Qumsiyeh, Mb; Rothstein, Jl; Fusco, A; Santoro, M; Zitzelsberger, H; Tallini, G.
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 1-gen-2006 Salvatore, Giuliana; DE FALCO, V; Melillo, Rm; Salerno, P; Nappi, Tc; Pepe, S; Troncone, G; Carlomagno, F; Wilhelm, Sm; Santoro, M.
BAY 43-9006 inhibition of oncogenic RET mutants. 1-gen-2006 Carlomagno, F; Anaganti, S; Guida, T; Salvatore, G; Troncone, G; Wilhelm, Sm; Santoro, M.
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 1-gen-2007 De Falco, V; Guarino, V; Avilla, E; Castellone, Md; Salerno, P; Salvatore, G; Faviana, P; Basolo, F; Santoro, M; Melillo, Rm.
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 1-gen-2007 Ugolini, C; Giannini, R; Lupi, C; Salvatore, Giuliana; Miccoli, P; Proietti, A; Elisei, R; Santoro, M; Basolo, F.
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 1-gen-2007 Salvatore, Giuliana; Nappi, Tc; Salerno, P; Jiang, Y; Garbi, C; Ugolini, ; Miccoli, P; Basolo, F; Castellone, Md; A., CIRAFICI AM; Melillo, Rm; Fusco, ; Bittner, M; Santoro, M.
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 1-gen-2007 Giannini, R; Ugolini, C; Lupi, C; Proietti, A; Elisei, R; Salvatore, Giuliana; Berti, P; Materazzi, G; Miccoli, P; Santoro, M; Basolo, F.
Receptor tyrosine kinase inhibitors in thyroid cancer 1-gen-2008 Castellone, Md; Carlomagno, F; Salvatore, Giuliana; Santoro, M.
Pros and cons of cellular studies in developing new drugs for thyroid cancers 1-gen-2008 Salvatore, Giuliana; Carlomagno, F; Santoro, M.
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 1-gen-2009 Nappi, Tc; Salerno, P; Zitzelsberger, H; Carlomagno, F; Salvatore, Giuliana; Santoro, M.
Morphological ultrasound microimaging of thyroid in living mice 1-gen-2009 Mancini, M; Vergara, E; Salvatore, Giuliana; Greco, A; Troncone, G; Affuso, A; Liuzzi, R; Salerno, P; SCOTTO DI SANTOLO, M; Santoro, M; Brunetti, A; Salvatore, M.
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 1-gen-2010 Laatikainen, Le; Castellone, Md; Hebrant, A; Hoste, C; Cantisani, Mc; Laurila, Jp; Salvatore, Giuliana; Salerno, P; Basolo, F; Näsman, J; Dumont, Je; Santoro, M; Laukkanen, Mo
Mostrati risultati da 21 a 40 di 71
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile